US frustration with pharmaceutical policy in Australia has grown in recent years, not just in relation to pricing but intellectual property and even biosimilars. …
New Stories
-
MA adopts Board changes
July 27, 2017 - Latest News -
Sigma and CW move to resolve supply dispute
July 27, 2017 - Latest News -
PSA backs ban on discounts to consumers
July 27, 2017 - Latest News -
Leaders out of step with public opinion on reputation
July 27, 2017 - Latest News -
New products lift Amgen
July 27, 2017 - Latest News -
A meaningless measure in the era of rebates
July 26, 2017 - Latest News -
Pharmacy loses a friend in Cabinet
July 26, 2017 - Latest News